miscarriage To Find a Reason A Columbia University doctor is seeking to use nanopore sequencing to uncover the cause of recurrent miscarriages, reports NBC News. Chromosomal Abnormalities Associated With Recurrent Miscarriage Emerge from Sequencing Study By combining conventional karyotyping and low-pass sequencing, researchers found chromosomal abnormalities in 1 in 8 couples with recurrent miscarriage. Pregnancy-Related Immune Changes Revealed by Single-Cell Placenta Sequencing Researchers identified immune activity changes in first-trimester placenta and decidua samples profiled through single-cell RNA sequencing. Cell-Free DNA Screening, Invasive Testing Show Similar Miscarriage Rates, Study Suggests A randomized clinical trial from France revealed similar miscarriage rates in women who had cell-free DNA screening for trisomy 21 prior to invasive testing. Testing for Complications Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports. Aug 10, 2016 Universal Diagnostic Laboratories to Market Combimatrix Miscarriage Test in California Jun 29, 2016 CombiMatrix Publishes 8K-Sample Study Supporting Superiority of Array Testing for Miscarriage Premium May 4, 2016 CombiMatrix Q1 Revenues Up 28 Percent Apr 26, 2016 CombiMatrix Gets Serious About Potential M&A Options in Wake of $8M Offering Premium Feb 17, 2016 CombiMatrix Q4 Revenues Rise 21 Percent on Higher Miscarriage, Fertility Test Volume Feb 1, 2016 UK Approves Fertility Research Project Using CRISPR in Human Embryos Sep 18, 2015 UK Scientists Apply for Permission to Edit Embryos With CRISPR/Cas9 in Miscarriage Study Aug 19, 2015 UConn Study Suggests SNP Arrays Add Value to Recurrent Pregnancy Loss Diagnosis Premium Mar 6, 2015 CombiMatrix Aims to Boost Reimbursement for Miscarriage Test Premium Jan 23, 2015 ReproSource Offering CombiMatrix's Miscarriage Analysis Test Oct 21, 2014 CombiMatrix Study Shows Arrays Outperform Standard Karyotyping in Thousands of Miscarriage Analyses Premium Oct 15, 2014 Natera Preps Move into Cancer Dx Market as it Continues Building NIPT Capabilities Jan 14, 2014 ProPath to Use CombiMatrix's Chromosomal Microarray Testing for Miscarriage Analysis Sep 17, 2013 Q&A: LabCorp's Peter Papenhausen on Embracing Chromosomal Microarray-Based Cancer Testing Premium Sep 12, 2013 Study Demonstrates Utility of Akonni TruTip Tech to Enrich Fetal DNA for NIPD Premium Aug 13, 2013 Manhattan Labs to Offer CombiMatrix Miscarriage Array Tests to New York Clients Jun 25, 2013 New York Grants Conditional OK for CombiMatrix Chromosomal Microarray Test for Miscarriage Analysis Jun 20, 2013 CombiMatrix Gains Rights to Provide Pathology's Miscarriage Tests Jun 18, 2013 Arrays Increasingly Adopted for Stillbirth Studies, though Questions about Cost, Counseling Remain Premium Aug 6, 2012 Wayne State Lands Grant for Fetal Dx Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.